News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
EU Backs AstraZeneca PLC and Pozen, Inc.'s Arthritis Pill, Vimovo
October 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Oct 11 (Reuters) - AstraZeneca (AZN.L) and Pozen (POZN.O) said on Monday their pain drug Vimovo had received agreement for marketing approval in 23 European Union countries.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
May 22, 2025
·
2 min read
·
Annalee Armstrong
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
May 22, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
‘We Don’t Believe This Is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
May 22, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
May 21, 2025
·
2 min read
·
Dan Samorodnitsky
